Human Milk has Anti-Oxidant Properties to Protect Premature Infants
Human milk (HM) is recognized as the optimal form of nutrition in the newborn period, providing nutrients and a variety of components (minerals, vitamins, enzymes, hormones, growth factors, and immunoglobulins) that are very important for growth and healthy development. In the case of premature (PM) infants, functional and in certain cases, structural development of most organ systems is completed in the weeks following birth. PM infants do not get enough oxygen and may require supplemental oxygen as high as 95%. This high level of inspired oxygen necessary to maintain arterial oxygen tension exposes these infants to more reactive oxygen species (ROS) compared with full term infants. ROS may lead to diseases associated with prematurity, including necrotizing enterocolitis, retinopathy of prematurity, intraventricular-periventricular hemorrhage, and bronchopulmonary dysplasia. There is then a need to reduce oxidative stress or boost antioxidant defenses in these vulnerable infants. Data suggest that HM has unique antioxidant properties that will assist the premature infant in coping with the increased oxidative stress. HM antioxidant components include the enzymes superoxide dismutase for dismutation of superoxide anion, catalase for degradation of hydrogen peroxide (H2O2), glutathione peroxidase for destruction of H2O2 and organic peroxides. Human milk contains other molecules including cysteine, vitamins C and E, which are scavengers of oxygen radicals.
Document Type: Research Article
Affiliations: Departments of Human Nutritional Sciences and Pediatrics, Faculties of Human Ecology and Medicine, University of Manitoba, Winnipeg, MB, Canada R3T 2N2; Canada.
Publication date: February 1, 2007
More about this publication?
- Current Pediatric Reviews publishes frontier reviews on all the latest advances in pediatric medicine. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in pediatric medicine.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content